how to withdraw money from jilibet to gcash

how to withdraw money from jilibet to gcash MINNEAPOLIS — The brazen killing of UnitedHealthcare CEO Brian Thompson has captivated the nation this week, as authorities continue to search for the man who fatally shot the Maple Grove resident outside an investors’ meeting in Manhattan earlier this week. As of Friday afternoon, police were testing DNA from a water bottle and examining a fake New Jersey ID and a cellphone that may be connected to the suspect, the New York Times reported . Friday evening, investigators found a backpack in Central Park like the one that had been carried by the shooter, police said. According to the Times, it was unclear if the gun used in the shooting was found in the bag. Investigators believed the gun possibly was fitted with a suppressor, or might have been a veterinary gun used by farmers and ranchers to put down animals without making a loud sound. The FBI also announced Friday night a $50,000 reward for information leading to an arrest and conviction. Here’s what else we know about the case, the company and Thompson himself: No motive as manhunt continues Authorities continue searching for the man who shot and killed Thompson in Manhattan. They have not released a name or motive. The shooter approached Thompson from behind and fired several times before he fled into an alley nearby and then hopped on an e-bike and rode north to Central Park, police said. The day after Thompson’s death, Maple Grove police reported bomb threats against two homes the family owns in the city. Investigators on Thursday released photos that partly reveal the face of a person of interest in the case. Authorities found at least one bullet casing on the scene with the word “deny” on it, reviving criticism of a company and industry that became known for denying medical care claims. Minnesota health care companies step up security Minnetonka-based Medica temporarily closed its headquarters Friday amid a “general feeling of vulnerability and concern” as insurers faced mounting online vitriol in the wake of Thompson’s killing. UnitedHealth Group’s note of remorse about Thompson’s killing has attracted more than 83,000 laughing emoji reactions on Facebook. A spokesperson said the company’s offices will be closed through Dec. 13, citing safety concerns that sprang up following Wednesday’s shooting. Other insurers have taken similar steps to reduce the visibility of top executives. While Minneapolis-based UCare remains open, its front doors were locked Friday morning. “Of course Brian Thompson’s murder — and the ensuing vitriol on social media — sent shockwaves throughout our industry,” UCare said in a statement. “We have no reason to believe there is any danger specifically to our team. At the same time, there is a general feeling of vulnerability and concern.” Thompson’s killing has prompted companies, especially those in health care, across the country to step up security. “It’s a wake-up call for a lot of companies,” said Glen Kucera, the New York-based president of Enhanced Protection Services, an arm of security company Allied Universal. “Unfortunately, it sometimes takes an event like this to impact change in the threat landscape.” What we know about Brian Thompson Thompson lived in Maple Grove . His wife, Paulette, works as a physical therapist with HealthPartners. They have two teenage sons, 19 and 16. Thompson worked at UnitedHealthcare for 20 years and was named its CEO in 2021 . The Minnesota Star Tribune reported this year that Thompson was among the state’s top-paid executives with a total compensation of $9.1 million. Both Thompson and his wife graduated from the University of Iowa, where he got a bachelor’s degree in business administration in 1997. He graduated with special honors. While Thompson wasn’t well-known to his neighbors — one said he was “very quiet” and another said “no one really knew him” on the block — his killing shook co-workers and local business leaders. He was known as a champion for UnitedHealthcare’s support of the Special Olympics and an advocate for American Sign Language access across health care. “Brian was a principled leader and a true champion in the healthcare community,” Roberta Antoine Dressen, CEO of local trade group Medical Alley, said in a statement. UnitedHealthcare is one of Minnesota’s largest employers UnitedHealthcare is the largest insurer in the U.S. It’s owned by Minnetonka-based UnitedHealth Group, which employs more than 400,000 people. It’s Minnesota’s 10th-largest employer — approximately 19,000 of its employees are stationed here. The company has its roots in the development of the health maintenance organization model of health care pioneered by Dr. Paul Ellwood in the 1960s and ‘70s. UnitedHealthcare has been criticized by media and elected officials because of the way the company reviews and denies requests and claims for medical care. The U.S. Senate Permanent Subcommittee on Investigations announced in October that UnitedHealthcare and two other major Medicare insurers inflated profits by denying seniors stays in care facilities while they recovered from injuries and illnesses. The company went from denying 10.9% of cases in 2020 to 22.7% in 2022, according to a report from the subcommittee. Minnesota lawmakers barred UnitedHealthcare and other HMOs from the state’s Medicaid program earlier this year. ©2024 The Minnesota Star Tribune. Visit startribune.com . Distributed by Tribune Content Agency, LLC

IMPD and City reach tentative contract deal with Fraternal Order of Police

As governments navigate the complexities of economic recovery and strive to build back better from the pandemic, a comprehensive and forward-thinking approach to consumption-boosting policies is paramount. By embracing innovation, sustainability, and collaboration, policymakers can create an enabling environment for consumer-driven growth, unleash market potential, and foster a resilient and thriving economy.Title: Cooperation with the Syrian Democratic Forces Alliance? Removing Terrorist Designations? A Statement from the US

Ahmedabad: Due to declining international prices, cotton rates have hit a three-year low of Rs 53,500 per candy (356 kg). Despite the peak season, Gujarat's ginning mills are experiencing financial difficulties following the price drop, with over 25% of units becoming non-operational. The state witnessed a daily arrival of 30,000 cotton bales (170 kg each), with the Cotton Corporation of India (CCI) making substantial purchases. Meanwhile, spinning units are operating at near-full capacity and showing positive financial results. " Cotton prices are at a three-year low below Rs 54,000 per candy. The ginning units are struggling as they bought raw cotton at higher rates. Now the rates are falling continuously, putting the mills under pressure. Ginning units have higher fixed costs; therefore, these units do business for turnover even after losses," states Apurva Shah, vice president, Gujarat Chamber of Commerce and Industry (GCCI). Industry reports indicate a decline in cotton cultivation in Gujarat, with an estimated production of 88 lakh bales this year, a decrease of 4 lakh bales compared to the previous year. "Nov to Jan is considered the peak cotton season, and despite that, ginning units are not operational at full capacity. Gujarat has around 800 ginning units; out of them, 450 are fully operational, while many are operational for a few days a week. About 20% of the mills have not started pressing this year," added Shah. Spinning facilities have become profitable as cotton prices have declined. "As of now, spinning units are witnessing some profitability as cotton prices have gone below the Rs 54,000 per candy level. Now, CCI is procuring a significant quantity, and we demand it should keep a reserve quota of cotton for the Indian textile industry to ensure the industry gets priority. Spinning mills in the state are running at almost full capacity, and yarn prices are currently Rs 240 per kg, but demand is not strong. So there is a fear that prices will reduce in a few days because cotton stock in the open market is reducing with strong buying by CCI," explained Jayesh Patel, senior vice president, Spinners' Association Gujarat (SAG). Stay updated with the latest news on Times of India . Don't miss the yearly horoscope 2025 and Chinese horoscope 2025 for Rat , Ox , Tiger , Rabbit , Dragon , Snake , Horse , Goat , Monkey , Rooster , Dog , and Pig zodiac signs. Spread love this holiday season with these New Year wishes and messages .

Armenia’s Shant Sargsyan and India’s Murali Karthikeyan secured victories to climb to the top of the standings after five rounds at the Qatar Masters Open, while title favourite Arjun Erigaisi joined the four-point club at Aspire Zone on Saturday. Playing white pieces on board 2, Sargsyan beat Bulgarian grandmaster Arkadij Naiditsh while Karthikeyan defeated Iran’s Pouya Idani on board 3 with black pieces as both of them took their points tallies to 4.5. Erigaisi, meanwhile, reached four points after beating his compatriot Surya Shekhar Ganguly. On the top board, Russia’s sixth seed Andrey Esipenko drew with Iran’s Bardiya Daneshvar, bringing both players to four points. UAE’s Salem Abdulrahman also secured his fourth point with a win over India’s Sankalp Gupta, while India’s Rithvik R Raja had the better of compatriot and 19th seed Pranav V to join the four-point pack. Nodirbek Abdusattorov of Uzbekistan, World No. 6 and last year’s runner-up beat India’s Ayush Sharma to reach 3.5 points. His compatriot and defending champion Nodirbek Yakubboev also drew with Lorenzo Lodici (Italy, 26th seed), leaving both players with 3.5 points. Iran’s 3rd seed Parham Maghsoodloo defeated Aditya Dipangkar of India, raising his score to 3.5 points. Meanwhile, the only Qatari player in the main tournament, International Master Husain Aziz drew with India’s Rajesh Nayak, raising his score to 1.5 points. Aziz had previously drawn with Mongolia’s Turmunkh Munkhzul in Round 4, lost to Cuba’s Luis Ernesto Quesada (the No. 27 seed), Uzbekistan’s Abdimalik Abdisalimov and settled for a draw in the opening round against China’s Zhihang Xu (ranked 35th). In the Qatar Masters Open B tournament being held simultaneously, India’s 12-year-old Abdul Khader Syed, Uzbek Samandar Shermuhammadov and Pakistan’s Lodhi Mahmood remained unbeaten. No. 2 seed Lodhi beat Khazakstan’s Yernur Akhmediyar to collect his fifth point, while Sayed defeated Uzbekistan’s Khudoyor Maraimov. Shermuhammadov beat Egypt’s Mohammed Salah Zozek. Among Qatari winners in the B tournament on Saturday were Layan al-Qassabi (defeated Saudi Arabia’s Maitha al-Otaibi), Hamad al-Kuwari (beat compatriot Ahmed Saif), Turki al-Kuwari (beat India’s Dahanaraja Srijan) and Fahad al-Mansoori (defeated Johan Jobsy of India). The youngest participant of the B tournament, 9-year-old Asma al-Hammadi of Qatar lost to India’s Rishi Ghanesharathinam. Commenting on the ongoing prestigious tournament, Hamad al-Tamimi, Executive Director of the Qatar Chess Federation and Championship Director, highlighted the fierce competition and unexpected results at the top boards. With four rounds yet to be played, he acknowledged the difficulty in predicting the eventual champion. Al-Tamimi also commended the strong performances of Qatari players and the seamless organisational efforts, emphasising the tournament’s pivotal role in nurturing chess talent and promoting the sport’s growth. Related Story QU launches 4th World Congress on Engineering and Technology Al Kuwari reelected president of Qatar Rugby and Hockey committeeBETHLEHEM, Pa. (AP) — Keith Higgins Jr. had 22 points to lead Lehigh to an 87-67 victory over Neumann on Sunday. Higgins added eight rebounds for the Mountain Hawks (5-6). Tyler Whitney-Sidney shot 7 for 12 (2 for 5 from 3-point range) and 3 of 3 from the free-throw line to add 19 points. Cam Gillus scored 10. Mike Smith III led the Knights with 15 points. Gary Francis added 12 points and DJ Earl had 12 points and three steals. Led by 13 points from Higgins before the break, Lehigh entered halftime tied with Neumann 42-42. Lehigh pulled away with a 9-0 run in the second half to extend a nine-point lead to 18 points. ___ The Associated Press created this story using technology provided by and data from . The Associated PressWith a quick and precise movement, the needle pierces the baby's skin, sending a sharp sensation through their tiny body. The suddenness of the prick catches the baby off guard, eliciting a gasp or a momentary pause in their breathing. The element of surprise adds an unexpected twist to the baby's emotional rollercoaster, leaving them momentarily stunned and bewildered.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE AmgenOklahoma residents on Sunday mourned the death of former Democratic U.S. Sen. Fred Harris, a trailblazer in progressive politics in the state who ran an unsuccessful presidential bid in 1976. Harris died on Saturday at 94. Democratic Party members across remembered Harris for his commitment to economic and social justice during the 1960s — a period of historical turbulence. Harris chaired the Democratic National Committee from 1969 to 1970 and helped unify the party after its tumultuous national convention in 1968 when protesters and police clashed in Chicago. “Fred Harris showed us what is possible when we lead with both heart and principle. He worked to ensure everyone had a voice and a seat at the table,” said Alicia Andrews, chair of the Oklahoma Democratic Party. Harris appeared at the in Chicago earlier this year as a guest speaker for the Oklahoma delegation, where he reflected on progress and unity. “Standing alongside him in Chicago this summer was a reminder of how his legacy continues to inspire,” Andrews said. Kalyn Free, a member of the Choctaw nation of Oklahoma and the DNC, said that there is no one else in public service whom she admired more than the former senator. “He was a friend, a mentor, a hero and my True North. Oklahoma and America have lost a powerful advocate and voice,” Free said in a statement. “His work for Indian Country will always be remembered.” “Senator Harris truly was an Oklahoma treasure and was ahead of his time in so many ways,” said Jeff Berrong, whose grandfather served in the state Senate with Harris. “He never forgot where he came from and he always remained focused on building a society that would provide equality of opportunity for all.” Harris served eight years in the state Senate before he was elected to the U.S. Senate, where he served another eight years before his 1976 presidential campaign. State party leaders commemorated his work on the National Advisory Commission on Civil Disorders, or the Kerner Commission, to investigate the 1960s riots. Harris was the last surviving member of the commission. Shortly after his presidential campaign, Harris left politics and moved to New Mexico and became a political science professor at the University of New Mexico. —- Lathan is a corps member for the Associated Press/Report for America Statehouse News Initiative. is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues.In conclusion, the incident at the Multi-Person Fainting Bathhouse serves as a wake-up call for the importance of maintaining high standards in public leisure facilities. The low ticket price of 9.9 yuan should not come at the expense of safety and quality of service. As the investigation unfolds, it is crucial for the management of the bathhouse to take proactive measures to address any deficiencies and regain the trust of their patrons. Only by prioritizing the well-being of their customers can businesses truly thrive in the competitive leisure market.SEOUL — South Korean President Yoon Suk-yeol , who stunned the world this week by declaring martial law , has narrowly avoided being impeached, as his party’s lawmakers boycotted the parliamentary vote on his ouster Saturday. The motion by opposition lawmakers accused him of insurrection, calling his decree an unconstitutional self-coup. “The president has betrayed the trust of the people and has lost the right to carry out state affairs,” the impeachment motion read. Thousands of protesters had gathered outside the National Assembly to cheer on his removal. Now protests are expected to build. “We will not give up. We will prevail,” liberal opposition leader Lee Jae-myung said after the motion fell through. “By Christmas, we will bring people the end-of-year gift of restoring the country to normalcy.” The liberal party said it would submit the motion again at the next parliamentary session on Wednesday — and every week after that until it passes. The question is whether enough members of Yoon’s conservative ruling party will vote to oust him while he still has 2 1⁄2 years remaining in his term, potentially ceding the presidency to the liberal opposition. Impeaching Yoon requires the support of at least two-thirds of the 300-member National Assembly — or 200 votes. Because the opposition coalition holds 192 seats, impeachment requires eight or more votes from Yoon’s conservative People Power Party. In the days following the martial law declaration, a handful of ruling party legislators had indicated they would at least consider impeachment. But only three of them showed up for the vote Saturday, with the remaining 105 leaving the plenary hall in protest. Outside the National Assembly, the crowd gathered to call for Yoon’s removal let out a cry of frustration. Among them were citizens who had traveled from hours away and college students studying for exams in the throng while keeping one eye on the news. “Arrest Yoon Suk-yeol!” they chanted as they marched down the promenade. In declaring martial law Tuesday, Yoon railed against the opposition-controlled National Assembly, which he accused of being a “den of criminals” and North Korea-sympathizers. Gen. Park An-su, whom Yoon designated as his martial law commander, subsequently suspended all political activity and declared the media under the military’s control. For many in South Korea , the move chillingly harked to the country’s past military dictatorships. But three hours after Yoon’s decree, legislators — many of them scaling the gates of the locked-down National Assembly — unanimously voted to overrule Yoon, requiring him to lift the decree. On Saturday morning, in a two-minute address to the nation, Yoon apologized for inconveniencing the public and said that he had been motivated by “desperation.” While Yoon reportedly told his officials and party members that his decree was meant to send a message to an adversarial legislature — which has filed numerous impeachments against his appointees and moved to investigate his wife on charges of graft and stock manipulation — many, including his own party members, say they believe he had much more sinister motives. Han Dong-hoon, the leader of the People Power Party, said that there were signs that the special forces soldiers who had stormed the National Assembly were acting on orders to arrest him and other legislators. Opposition leader Lee, whom Yoon narrowly defeated in the presidential election two years ago, has said the same. “We’ve confirmed that President Yoon ordered the arrest of major politicians on the grounds that they were anti-state forces,” Han said at a party meeting Friday. “I don’t think we can pretend like nothing happened.” While stating that this was based on “credible” sources, Han did not elaborate, offering only that these plans would be made public in due time “through various channels.” In a meeting with Han that same day, Yoon denied giving such an order, Han said. Hong Jang-won, a senior official at the National Intelligence Service, the country’s spy agency , told lawmakers Friday that Yoon called him to order the arrest of several lawmakers, including party leaders Lee and Han. Spy chief Cho Tae-yong has disputed Hong’s allegations. Yet even while condemning the martial law declaration as unconstitutional and acknowledging that Yoon must ultimately be removed from office, Han and most of his party allies balked at impeachment. For the South Korean conservatives, impeachment is their exposed nerve, and they have reason to tread lightly. The first and only South Korean president to be successfully impeached was conservative Park Geun-hye, who was later investigated and jailed on corruption charges. Her downfall splintered the conservative camp and opened a path for liberal successor Moon Jae-in, whose term conservatives refer to as “the lost five years.” Crucial to the success of Park’s impeachment was a bloc of conservative legislators who joined the opposition to vote in favor. It is why many party stalwarts are determined to avoid the same fate this time around. “We cannot have any more traitors surrendering to the enemy, like the time with Park Geun-hye,” Daegu Mayor Hong Joon-pyo wrote on social media Wednesday. Instead, Yoon’s party members have floated more moderate solutions that would make way for Yoon’s “orderly resignation,” such as revising the constitution to shorten Yoon’s term, transferring some of his presidential powers to the prime minister or forming a bipartisan Cabinet. In his recent public address, Yoon said he would leave his fate to the party, hinting that he may relinquish much of his authority to Han, should he avoid impeachment. The liberal opposition has rejected any alternatives to impeachment, calling Yoon a “ticking time bomb.” “He is in a very troubling mental state right now. We don’t have time to discuss something like ‘an orderly resignation,’ ” liberal party spokesperson Yoon Jong-kun told reporters Saturday morning. “Only Yoon’s immediate removal from official duties and impeachment can alleviate the anger of the people and South Korea’ s plummeting international credit rating.” The liberal party has said that it would propose the motion again Wednesday. “We are going to propose it repeatedly,” Lee Jae-myung said, “until it goes through.”